REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection

Clinical trial NCT02233075 · COMPLETED

Trial details

NCT number: NCT02233075
Sponsor: Replicor Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic HBV Infection (HBeAg Negative)

Start date: 2014-09-01
Primary completion: 2016-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.